Malignant Giant Cell Neoplasm — Trials

Malignant Giant Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

107 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00238303	Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme	completed	Phase 2	103	National Cancer Institute (NCI)NIH	1	May 23, 2014	clinicaltrials
NCT00641706	Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme	completed	Phase 2	44	National Cancer Institute (NCI)NIH	1	May 14, 2014	clinicaltrials